{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T15:27:57Z","timestamp":1789140477204,"version":"build-2803163510"},"reference-count":28,"publisher":"Japanese Society of Internal Medicine","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026,1,1]]},"DOI":"10.2169\/internalmedicine.5432-25","type":"journal-article","created":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T18:07:26Z","timestamp":1750270046000},"page":"96-102","source":"Crossref","is-referenced-by-count":3,"title":["Vonoprazan vs. Esomeprazole: Scarring Rate of Post-endoscopic Submucosal Dissection Ulcers in the Postoperative Stomach"],"prefix":"10.2169","volume":"65","author":[{"given":"Kosuke","family":"Nomura","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Toranomon Hospital, Japan"},{"name":"Department of Gastroenterology, Hiroo Clinic, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yugo","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Toranomon Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yorinari","family":"Ochiai","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Toranomon Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junnosuke","family":"Hayasaka","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Toranomon Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Mitsunaga","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Toranomon Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Odagiri","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Toranomon Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Yamashita","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Toranomon Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Matsui","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Toranomon Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Kikuchi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Toranomon Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Hoteya","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Toranomon Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Cho SB, Yoon KW, Park SY, et al. Risk factors for food residue after distal gastrectomy and a new effective preparation for endoscopy: the water-intake method. Gut Liver 3: 186-191, 2009.","DOI":"10.5009\/gnl.2009.3.3.186"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Ahn JY, Jung HY, Bae SE, et al. Proper preparation to reduce endoscopic reexamination due to food residue after distal gastrectomy for gastric cancer. Surg Endosc 27: 910-917, 2013.","DOI":"10.1007\/s00464-012-2532-9"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Kubo M, Sasako M, Gotoda T, et al. Endoscopic evaluation of the remnant stomach after gastrectomy: proposal for a new classification. Gastric Cancer 5: 83-89, 2002.","DOI":"10.1007\/s101200200014"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Jung HJ, Lee JH, Ryu KW, et al. The influence of reconstruction methods on food retention phenomenon in the remnant stomach after a subtotal gastrectomy. J Surg Oncol 98: 11-14, 2008.","DOI":"10.1002\/jso.21076"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Nozaki I, Hato S, Hori S, Nishide N, Kurita A. Incidence of food residue interfering with postoperative endoscopic examination for gastric pull-up after esophagectomy. Esophagus 13: 195-199, 2016.","DOI":"10.1007\/s10388-015-0516-2"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Hershcovic T, Fass R. Management of gastroesophageal reflux disease that does not respond well to proton pump inhibitors. Curr Opin Gastroenterol 26: 367, 2010.","DOI":"10.1097\/MOG.0b013e32833ae2be"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Andersson K, Carlsson E. Potassium-competitive acid blockade: a new therapeutic strategy in acid-related diseases. Pharmacol Ther 108: 294-307, 2005.","DOI":"10.1016\/j.pharmthera.2005.05.005"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Hori Y, Imanishi A, Matsukawa J, et al. 1-[5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1<i>H<\/i>-pyrrol-3-yl]-<i>N<\/i>-methylmethanamine monofumarate (TAK-438), a novel and potent potassium-competitive acid blocker for the treatment of acid-related diseases. J Pharmacol Exp Ther 335: 231-238, 2010.","DOI":"10.1124\/jpet.110.170274"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Sakurai Y, Mori Y, Okamoto H, et al. Acid-inhibitory effects of vonoprazan 20 mg compared with esomeprazole 20 mg or rabeprazole 10 mg in healthy adult male subjects - a randomised open-label cross-over study. Aliment Pharmacol Ther 42: 719-730, 2015.","DOI":"10.1111\/apt.13325"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. Garnock-Jones KP. Vonoprazan: first global approval. Drugs 75: 439-443, 2015.","DOI":"10.1007\/s40265-015-0368-z"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Murakami K, Sakurai Y, Shiino M, Funao N, Nishimura A, Asaka M. Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a phase III, randomised, double-blind study. Gut 65: 1439-1446, 2016.","DOI":"10.1136\/gutjnl-2015-311304"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Yamasaki A, Yoshio T, Muramatsu Y, et al. Vonoprazan is superior to rabeprazole for healing endoscopic submucosal dissection: induced ulcers. Digestion 97: 170-176, 2018.","DOI":"10.1159\/000485028"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Ishii Y, Yamada H, Sato T, et al. Effects of vonoprazan compared with esomeprazole on the healing of artificial postendoscopic submucosal dissection ulcers: a prospective, multicenter, two-arm, randomized controlled trial. Gastroenterol Res Pract 18: 1615092, 2018.","DOI":"10.1155\/2018\/1615092"},{"key":"14","unstructured":"14. Patel A, Hazzan R, Goldberg E, et al. AGA clinical practice update on the use of potassium-competitive acid blockers for acid-related disorders: expert review. Gastroenterology 163: 758-768, 2022."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Nomura K, Hoteya S, Kikuchi D, Inoshita N, Iizuka T. Utility of endoscopic submucosal dissection in the remnant stomach and clinical outcomes for different reconstruction methods. Digestion 100: 254-261, 2019.","DOI":"10.1159\/000495346"},{"key":"16","doi-asserted-by":"publisher","unstructured":"16. Yamamoto H, Kawata H, Sunada K, et al. Successful en-bloc resection of large superficial tumors in the stomach and colon using sodium hyaluronate and small-caliber-tip transparent hood. Endoscopy 35: 690-694, 2003.","DOI":"10.1055\/s-2003-41516"},{"key":"17","unstructured":"17. Sakita T, Fukutomi H. Endoscopic diagnosis. In: Ulcer of Stomach and Duodenum. Yoshitoshi Y, Ed. Nankodo Publishing, Tokyo, 1971: 197-208 (in Japanese)."},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Ashida K, Sakurai Y, Hori T, et al. Randomised clinical trial: vonoprazan, a novel potassium-competitive acid blocker, vs. lansoprazole for the healing of erosive oesophagitis. Aliment Pharmacol Ther 43: 240-251, 2016.","DOI":"10.1111\/apt.13461"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Shichijo S, Hirata Y, Niikura R, et al. Vonoprazan versus conventional proton pump inhibitor-based triple therapy as first-line treatment against <i>Helicobacter pylori<\/i>: a multicenter retrospective study in clinical practice. J Dig Dis 17: 670-675, 2016.","DOI":"10.1111\/1751-2980.12398"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Maruoka D, Arai M, Kasamatsu S, et al. Vonoprazan is superior to proton pump inhibitors in healing artificial ulcers of the stomach post-endoscopic submucosal dissection: a propensity score-matching analysis. Dig Endosc 29: 57-64, 2017.","DOI":"10.1111\/den.12705"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Horikawa Y, Mizutamari H, Mimori N, et al. Short-term efficacy of potassium-competitive acid blocker following gastric endoscopic submucosal dissection: a propensity score analysis. Scand J Gastroenterol 53: 243-251, 2018.","DOI":"10.1080\/00365521.2017.1410569"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Hirai A, Takeuchi T, Takahashi Y, et al. Comparison of the effects of vonoprazan and lansoprazole for treating endoscopic submucosal dissection-induced artificial ulcers. Dig Dis Sci 63: 974-981, 2018.","DOI":"10.1007\/s10620-018-4948-0"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Shimozato A, Sasaki M, Ogasawara N, et al. Risk factors for delayed ulcer healing after endoscopic submucosal dissection of gastric neoplasms. J Gastrointestin Liver Dis 26: 363-368, 2017.","DOI":"10.15403\/jgld.2014.1121.264.kas"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Ichida T, Ueyama S, Eto T, Kusano F, Sakai Y. Randomized controlled trial comparing the effects of vonoprazan plus rebamipide and esomeprazole plus rebamipide on gastric ulcer healing induced by endoscopic submucosal dissection. Intern Med 58: 159-166, 2019.","DOI":"10.2169\/internalmedicine.1146-18"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Hamada K, Uedo N, Tonai Y, et al. Efficacy of vonoprazan in prevention of bleeding from endoscopic submucosal dissection-induced gastric ulcers: a prospective randomized phase II study. J Gastroenterol 54: 122-130, 2019.","DOI":"10.1007\/s00535-018-1487-6"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Ochiai Y, Iizuka T, Hoshihara Y, et al. Efficacy of vonoprazan for refractory reflux esophagitis after esophagectomy. Dig Dis 39: 569-576, 2021.","DOI":"10.1159\/000515146"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. McKeage K, Blick SK, Croxtall JD. Esomeprazole: a review of its use in the management of gastric acid-related diseases in adults. Drugs 68: 1571-1607, 2008.","DOI":"10.2165\/00003495-200868110-00009"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Lee MS, Ahn SH, Lee JH, et al. What is the best reconstruction method after distal gastrectomy for gastric cancer? Surg Endosc 26: 1539-1547, 2012.","DOI":"10.1007\/s00464-011-2064-8"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/1\/65_5432-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T03:26:32Z","timestamp":1767410792000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/1\/65_5432-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.5432-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,1]]},"article-number":"5432-25"}}